Delivery Order SPE2DB22D2007-SPE2DB24FH8XD
- Not listed
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $9,192.90 firm fixed price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a completion date of January 19, 2024 and was awarded on December 27, 2023. No set-aside designation was used for this...
- The Defense Logistics Agency awarded a $3,354.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 17, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion...
- The Defense Logistics Agency awarded a $2,174.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562069577 units of HYPERRAB 300 UNIT/ML vials. The contract has a period of performance from September 6 through September 27, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier to the Department of Defense, Amerisourcebergen will deliver this pharmaceutical product in...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,812 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 300 units of HYPERRAB 300 UNIT/ML vials. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 6, 2023 through September 27, 2023. No subcontractors or set aside designations were...
- Defense Logistics Agency awarded a $1,087.20 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4562519778 HYPERRAB 300 UNIT/ML VIALML. As the parent company, Amerisourcebergen Corporation will deliver the products from its Conshohocken, Pennsylvania facility in support of DLA programs. The delivery order was issued on October 17, 2023 under an existing vehicle and has a completion date of November 7, 2023. No set-aside provisions were specified for this award to supply the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $116,341.20 contract is for the delivery of HYPERRAB 300 VIAL 5ML pharmaceutical products. Amerisourcebergen Drug Corp, a for-profit organization, has provided a range of pharmaceutical and medical supplies to support DLA Troop Support Medical programs. The contract has no set-aside designation and the...
- The Defense Logistics Agency awarded a $14,053.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML) on May 30, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation and will be...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $27,578.70 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4562267407 HYPERRAB 300 UNIT/ML VIAL 5ML. The contract has a period of performance from September 21, 2023 through October 13, 2023. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,372.40, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of May 14, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor, and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product, with a ceiling value of $3,721.90. The contract is a firm fixed-price delivery order with a period of performance through November 1, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH8XDDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $2,249.12 firm fixed price order is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product. No set-aside designation was used. The order has a completion date of February 13, 2024 and was awarded on January 23, 2024. AmerisourceBergen Drug Corp has received numerous prior federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop Support Medical programs. This specific order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/23/24 |